Initial uptake, time to treatment, and real-world effectiveness of all-oral direct-acting antivirals for hepatitis C virus infection in the United States: A retrospective cohort analysis

BACKGROUND: Data on initiation and utilization of direct-acting antiviral therapies for hepatitis C virus infection in the United States are limited. This study evaluated treatment initiation, time to treatment, and real-world effectiveness of direct-acting antiviral therapy in individuals with hepa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwo, Paul Y., Puenpatom, Amy, Zhang, Zuoyi, Hui, Siu L., Kelley, Andrea A., Muschi, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6705774/
https://www.ncbi.nlm.nih.gov/pubmed/31437170
http://dx.doi.org/10.1371/journal.pone.0218759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6705774/
https://www.ncbi.nlm.nih.gov/pubmed/31437170
http://dx.doi.org/10.1371/journal.pone.0218759

Ejemplares similares